
CureDuchenne Celebrates FDA Approval of First Drug for Duchenne Muscular Dystrophy
Eteplirsen, Developed by Sarepta, Was Made Possible in Part by Early Funding from CureDuchenne NEWPORT BEACH, California, September 19, 2016 – CureDuchenne applauds the first-ever approval of a drug in […]


